FREDERICK, MD--(Marketwired - Apr 7, 2017) - BioElectronics Corporation (OTC PINK: BIEL), the maker of advanced noninvasive
bioelectronic pain management medical devices, is pleased to announce that its devices are being featured at the 2017 Australian
Pain Society 37th Annual Scientific Meeting, Sunday April 9th, 2017 - April 12th, 2017 http://www.dcconferences.com.au/aps2017/index.asp. The conference is
focused on the basic science and treatment of pain for physicians, nurses, physical therapists, and researchers. The meeting
participants include Mundipharma, Pfizer, GE Healthcare, Halyard, Abbott and leading Australian pain researchers.
BioElectronics' flagship product ActiPatch® Musculoskeletal Pain Therapy is a drug-free, wearable nonprescription medical
device that provides 720-hours of on/off therapy to relieve chronic pain.
"We are making excellent progress in achieving product placement in our major pharmacy chains. This pain conference is an
exceptional opportunity to create product awareness in the medical community," said Rob Gourlay of Evomed, the distributor of
Actipatch in Australia and New Zealand. www.evomed.com.au
About BioElectronics Corporation
BioElectronics Corporation is a leader in biophysics and the maker of ActiPatch® Therapy for back pain and other musculoskeletal
complaints, RecoveryRx® Devices for chronic wounds and post-operative wound care, and Allay® Menstrual Pain Therapy. For clinical
and more information, please visit www.bielcorp.com.